MedC waxay horey ugu maalgashatay horumarinta daaweynta ee hay'adda cilmi baarista beeraha ee Israel, Xarunta Volcani
Shirkadda MedC Biopharma Corporation ee Canada ayaa horaantii bishan ku dhawaaqday in ay haysato heshiis shati oo caalami ah oo loogu talagalay daaweynta kansarka ku salaysan kansarka, oo ay soo saareen hay'adda cilmi baarista beeraha ee dalka Israel (ARO), Volcani Center.
MedC, oo ay aasaaseen walaalaha Israel Avi iyo Guy Drori, ayaa sidoo kale ku dhawaaqay iskaashi ay la leeyihiin shirkad hoosaad ka ah Israel oo la yiraahdo Nextar Chempharma Solutions, oo ah shirkad ka shaqeysa horumarinta daroogada iyo shirkadaha wax soo saarka, si loo horumariyo daaweynta.
Xarunta Volcani Centre ayaa isku diyaarineysa in ay diiwaangeliso dukumintiyada daaweynta nukliyeerka T-cell-ka ah (CTCL), nooc ka mid ah kansarka difaaca jirka kaas oo lagu sifeeyey cudur Cagaaran ee Maamulka Cuntada iyo Dawooyinka ee Maraykanka. Dhibaatooyinka kiliiniga waxaa loo qorsheeyaa bilowga 2019.
Akhri qodobada oo dhan Calcalistech.com (ilo)
